Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes

Abstract Background Atherosclerotic cardiovascular diseases (CVD) is the leading cause of death in diabetes, but the full range of biomarkers reflecting atherosclerotic burden and CVD risk in people with diabetes is unknown. Metabolomics may help identify novel biomarkers potentially involved in dev...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Zhe Huang, Lucija Klaric, Justina Krasauskaite, Stela McLachlan, Mark W. J. Strachan, James F. Wilson, Jackie F. Price
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2022-04-01
Edice:	Cardiovascular Diabetology
Témata:	Atherosclerosis Cardiovascular diseases Glycolysis Lactate Lipidomics Metabolomics
On-line přístup:	https://doi.org/10.1186/s12933-022-01493-w
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!